daunorubicin has been researched along with oligonucleotides in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Hassur, SM; Whitlock, HW | 1 |
| Patel, DJ | 1 |
| Gottikh, MB; Krynetskaya, NF; Shabarova, ZA | 1 |
| Dikalov, SI; Frolova, EI; Godovikova, TS; Rumyantseva, GV; Sergejev, DS; Weiner, LM; Zarytova, VF | 1 |
| Gottikh, MB; Ivanovskaia, MG; Shabarova, ZA; Skripkin, EA | 1 |
| Arcamone, F; Battistini, C; Capobianco, M; Colonna, FP; Garbesi, A; Razzano, G; Rizzo, V; Sacchi, N; Tondelli, L; Vigevani, A | 1 |
| Borah, B; Cohen, JS; Roy, S; Zon, G | 1 |
| Eckle, E; Kiefer, E; Lauser, G; Stezowski, JJ | 1 |
| Cavailles, JA; Herve, M; Huynh-Dinh, T; Igolen, J; Langlois d'Estaintot, B; Neumann, JM; Tran-Dinh, S | 1 |
| Quigley, GJ; Rich, A; Ughetto, G; van Boom, JH; van der Marel, G; Wang, AH | 1 |
| Arcamone, F; Bonazzi, S; Capobianco, ML; Garbesi, A; Giannini, G; Zanella, S | 1 |
| Arcamone, FM; Raffaelli, A; Salvadori, P; Triolo, A | 1 |
| Bernhard, WA; Hu, GG; Milano, MT; Williams, LD | 1 |
| Harrington, DJ; Koch, TH; Podell, ER; Taatjes, DJ | 1 |
| Beck, JL; Kapur, A; Sheil, MM | 1 |
| Anichini, M; Chiti, G; Marrazza, G; Mascini, M | 1 |
| Arcamone, F; Capobianco, ML; Carbone, GM; Catapano, CV; Dembech, C; Flanagan, CE; McGuffie, E; Napoli, S; Negri, U | 1 |
| Arcamone, F; B Arimondo, P; Capobianco, ML; De Champdoré, M; Garbesi, A; Guianvarc'h, D | 1 |
| Aran, JM; Gottesman, MM; Pétriz, J | 1 |
| Andrushchenko, V; Pandyra, A; Tsankov, D; van de Sande, JH; Wieser, H | 1 |
| Arcamone, F; Capobianco, ML; Carbone, GM; Catapano, CV; Napoli, S; Negri, U | 1 |
| Arimondo, PB; Capobianco, ML; Duca, M; Halby, L; Jollès, B; Laigle, A; Senamaud-Beaufort, C; Stierlé, V | 1 |
| Chen, X; Deng, S; Li, Y; Lin, H; Liu, B; Ou, X; Peng, Y; Sun, X; Wu, Z; Xu, Y; Yan, S; Zhang, L; Zhao, P; Zheng, H | 1 |
| Chen, J; Zhang, W; Zhu, Y | 1 |
24 other study(ies) available for daunorubicin and oligonucleotides
| Article | Year |
|---|---|
A gel electrophoresis method for determining the relative binding constants of biologically active, intercalating fluorescent stains.
Topics: Binding Sites; Daunorubicin; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Ethidium; Fluorescent Dyes; Methods; Oligodeoxyribonucleotides; Oligonucleotides; Osmolar Concentration; Spectrophotometry; Time Factors | 1979 |
Helix-coil transition of the dG-dC-dG-dC self-complementary duplex and complex formation with daunomycin in solution.
Topics: Daunorubicin; Magnetic Resonance Spectroscopy; Molecular Conformation; Oligodeoxyribonucleotides; Oligonucleotides | 1979 |
Oligonucleotide derivatives resistant to the cell nuclease degradation and effective for the RNA hydrolysis by RNase H.
Topics: Animals; Carcinoma, Krebs 2; Daunorubicin; Escherichia coli; Ethidium; Ethylenediamines; Indicators and Reagents; Mice; Oligonucleotides; Ribonuclease H; Ribonucleases; RNA; RNA, Ribosomal, 5S; Substrate Specificity | 1991 |
Hydroxyl radical generation by oligonucleotide derivatives of anthracycline antibiotic and synthetic quinone.
Topics: Base Sequence; Cyclic N-Oxides; Daunorubicin; Electron Spin Resonance Spectroscopy; Hydroxides; Hydroxyl Radical; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Structure; NADPH-Ferrihemoprotein Reductase; Naphthoquinones; Oligonucleotides; Spin Labels | 1991 |
[Design of new oligonucleotide derivatives resistant to cell nucleases].
Topics: Chemical Phenomena; Chemistry; Daunorubicin; Deoxyribonucleases; Drug Design; Drug Stability; Hydrolysis; Intercalating Agents; Oligonucleotides | 1990 |
Association of anthracyclines and synthetic hexanucleotides. Structural factors influencing sequence specificity.
Topics: Antibiotics, Antineoplastic; Base Sequence; Binding Sites; Chemical Phenomena; Chemistry; Daunorubicin; DNA; Doxorubicin; Oligonucleotides; Spectrometry, Fluorescence | 1989 |
Unique pyrimidine 2D-COSY aromatic cross-peaks as monitors of pyrimidine environments and mobility in oligo- and polynucleotides.
Topics: Base Composition; Binding Sites; Cytidine; Daunorubicin; Magnetic Resonance Spectroscopy; Oligonucleotides; Protons; Pyrimidine Nucleotides; Pyrimidines; RNA, Transfer; Temperature | 1985 |
Molecular level studies with anthracyclines.
Topics: Antibiotics, Antineoplastic; Crystallography; Daunorubicin; Molecular Conformation; Naphthacenes; Oligonucleotides; Structure-Activity Relationship | 1985 |
500 MHz 1H-NMR study of the interaction of daunomycin with B and Z helices of d(CGm5CGCG).
Topics: Daunorubicin; Magnetic Resonance Spectroscopy; Nucleic Acid Conformation; Oligodeoxyribonucleotides; Oligonucleotides | 1985 |
Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).
Topics: Daunorubicin; Hydrogen Bonding; Models, Molecular; Nucleic Acid Conformation; Oligodeoxyribonucleotides; Oligonucleotides; Structure-Activity Relationship; Water; X-Ray Diffraction | 1980 |
Synthesis and binding properties of conjugates between oligodeoxynucleotides and daunorubicin derivatives.
Topics: Antibiotics, Antineoplastic; Daunorubicin; DNA; Nucleic Acid Conformation; Oligonucleotides; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1997 |
Non-covalent complexes between DNA-binding drugs and double-stranded deoxyoligonucleotides: a study by ionspray mass spectrometry.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Binding, Competitive; Daunorubicin; Distamycins; DNA; Mass Spectrometry; Oligonucleotides | 1997 |
Migration of electrons and holes in crystalline d(CGATCG)-anthracycline complexes X-irradiated at 4 K.
Topics: Animals; Antibiotics, Antineoplastic; Cattle; Chemical Phenomena; Chemistry, Physical; Crystallization; Daunorubicin; DNA; DNA Adducts; Doxorubicin; Electron Spin Resonance Spectroscopy; Electrons; Oligonucleotides; X-Rays | 1998 |
Crystal structure of epidoxorubicin-formaldehyde virtual crosslink of DNA and evidence for its formation in human breast-cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cross-Linking Reagents; Crystallography, X-Ray; Daunorubicin; DNA Adducts; DNA, Neoplasm; Epirubicin; Humans; Intercalating Agents; Nucleic Acid Conformation; Oligonucleotides; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Observation of daunomycin and nogalamycin complexes with duplex DNA using electrospray ionisation mass spectrometry.
Topics: Antibiotics, Antineoplastic; Binding, Competitive; Daunorubicin; DNA; Hydrogen-Ion Concentration; Indicators and Reagents; Mass Spectrometry; Nogalamycin; Oligonucleotides | 1999 |
Detection of human apolipoprotein E genotypes by DNA electrochemical biosensor coupled with PCR.
Topics: Apolipoproteins E; Biosensing Techniques; Carbon; Daunorubicin; DNA; Electrodes; Genotype; Humans; Oligonucleotides; Polymerase Chain Reaction; Polymorphism, Genetic | 2000 |
DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Topics: Antibiotics, Antineoplastic; Base Sequence; Binding Sites; Cell Line, Tumor; Daunorubicin; DNA; Drug Design; Gene Targeting; Genes, myc; Humans; Molecular Sequence Data; Oligonucleotides; Promoter Regions, Genetic; Transcription, Genetic | 2004 |
Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
Topics: Anti-HIV Agents; Binding, Competitive; Daunorubicin; DNA; HIV-1; Hydrolysis; Molecular Conformation; Oligonucleotides; Purines; Temperature | 2005 |
An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein.
Topics: Amino Acid Sequence; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line; Cell Survival; Daunorubicin; DNA Primers; Dogs; Doxorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluorescence; Fluorescent Antibody Technique; Gene Fusion; Genes, MDR; Genetic Vectors; Green Fluorescent Proteins; Humans; Microscopy, Confocal; Molecular Sequence Data; Oligonucleotides; Rhodamine 123; Subcellular Fractions; Transfection | 2004 |
Intercalation of daunomycin into d(CG)4 oligomer duplex containing G x T mismatches by vibrational circular dichroism and infrared absorption spectroscopy.
Topics: Base Pair Mismatch; Base Sequence; Circular Dichroism; Daunorubicin; Intercalating Agents; Models, Molecular; Oligonucleotides; Spectrophotometry, Infrared | 2006 |
Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line, Tumor; Daunorubicin; Genes, myc; Growth Inhibitors; Humans; Male; Oligonucleotides; Promoter Regions, Genetic; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Transcription, Genetic | 2006 |
Targeting MDR1 gene: synthesis and cellular study of modified daunomycin-triplex-forming oligonucleotide conjugates able to inhibit gene expression in resistant cell lines.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Line, Tumor; Daunorubicin; DNA; Down-Regulation; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Mice; Molecular Sequence Data; NIH 3T3 Cells; Oligonucleotides; Spectrometry, Fluorescence; Transfection | 2008 |
Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy.
Topics: A549 Cells; Antineoplastic Agents; Aptamers, Nucleotide; Cell Movement; Daunorubicin; Drug Delivery Systems; Ferric Compounds; G-Quadruplexes; Humans; Magnetite Nanoparticles; Nucleic Acid Hybridization; Oligonucleotides; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2019 |
Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles.
Topics: Animals; Cell Line, Tumor; Daunorubicin; Drug Delivery Systems; Leukemia; Ligands; Luteolin; Mice; Nanoparticles; Oligonucleotides; Transferrin | 2023 |